Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Portfolio Strategy
Optimizing the Value of Product Portfolios
We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio. We also bring transaction support capabilities to help put strategies into action. In the last five years alone, we have completed more than 200 projects related to portfolio strategy.
Services
- Therapeutic Area and Franchise Strategy
Our goal is to help customers enter key areas with confidence. Within oncology alone, we bring portfolio planning experience in 20+ tumor types across a broad spectrum of mechanistic classes. Offerings include:
- Situation Assessment (Current and Future)
- Vision and Goals
- Asset Identification, Assessment, and Prioritization
- Disease / Therapeutic Area Strategy
- Business Development and Licensing
Get independent advice and support for mergers and acquisitions (M&A), licensing, collaborations, joint ventures, divestitures, and capital raising.
Learn more here
Decision Science
A science-based approach to strategic planning and decision making is critically important. When key decisions are backed by a rigorous and logical process, it maximizes your likelihood of success. Blue Matter’s Decision Path™ framework is specifically tailored for biopharma, and we use it to help our clients with their most important strategic plans and decisions.
Learn more hereFeatured Case Studies
Thought Leadership
Portfolio Forecasting (Part 1): Finding the Optimum Approach to Portfolio Valuation
August 18, 2025
How Science Can Drive Better Business Decisions in Biopharma
June 24, 2025
